home · filing · 0001140361-22-026739
8-K
filed July 22, 2022, 7:59 PM ET
ticker ADNH
CIK 0001744494
leadership
confidence high
sentiment neutral
materiality 0.35
Director Christos Kaskavelis resigns board, insider Nora Gourdoupi appointed to Advent board
ADVENT TECHNOLOGIES HOLDINGS, INC.
Dr. Christos Kaskavelis resigned from Advent's board on July 19, 2022, remains Chief Marketing Officer.
Dr. Panoraia 'Nora' Gourdoupi appointed to board on July 20, 2022, filling the Class III term.
Gourdoupi is SVP of Corporate Business Developments, Advent employee since 2006, co-inventor of 18 patents.
She will receive no separate director compensation; only her executive compensation continues.
Press release highlights Gourdoupi's role in securing the Green HiPo project approval.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2022-07-19
Successor Panoraia 'Nora' Gourdoupi
Filed July 22, 2022, 7:59 PM ET
On July 19, 2022, Dr. Christos Kaskavelis submitted his resignation from the Board of Directors (the “Board”) of Advent Technologies Holdings, Inc.
Effective 2022-07-20
Filed July 22, 2022, 7:59 PM ET
On July 20, 2022, the Board appointed Dr. Panoraia ‘Nora’ Gourdoupi as a director to fulfill the position vacated by Dr. Kaskavelis’ resignation.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Christos Kaskavelis resigned as Director at ADVENT TECHNOLOGIES HOLDINGS, INC..
Action resigned
Role Director
Exact text from the filing
On July 19, 2022, Dr. Christos Kaskavelis submitted his resignation from the Board of Directors (the “Board”) of Advent Technologies Holdings, Inc.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Panoraia 'Nora' Gourdoupi was appointed as Director at ADVENT TECHNOLOGIES HOLDINGS, INC..
Action appointed
Role Director
Exact text from the filing
On July 20, 2022, the Board appointed Dr. Panoraia ‘Nora’ Gourdoupi as a director to fulfill the position vacated by Dr. Kaskavelis’ resignation.
View on SEC.gov
Source: SEC EDGAR
accession 0001140361-22-026739
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.